Benzinga | Jan 7, 2022 01:08PM EST

Credit Suisse Downgrades Clover Health Investments to Underperform, Lowers Price Target to $3.5

Credit Suisse downgrades Clover Health Investments (NASDAQ:CLOV) from Neutral to Underperform and lowers the price target from $9 to $3.5.